TY - JOUR AU - Chan, A. T. AU - Giovannucci, E. L. AU - Meyerhardt, J. A. AU - Schernhammer, E. S. AU - Curhan, G. C. AU - Fuchs, C. S. PY - 2005 DA - 2005// TI - Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer JO - JAMA VL - 294 UR - https://doi.org/10.1001/jama.294.8.914 DO - 10.1001/jama.294.8.914 ID - Chan2005 ER - TY - JOUR AU - Chubak, J. AU - Whitlock, E. P. AU - Williams, S. B. AU - Kamineni, A. AU - Burda, B. U. AU - Buist, D. S. PY - 2016 DA - 2016// TI - Aspirin for the prevention of Cancer incidence and mortality: systematic evidence reviews for the U.S. preventive services task force JO - Ann Intern Med VL - 164 UR - https://doi.org/10.7326/M15-2117 DO - 10.7326/M15-2117 ID - Chubak2016 ER - TY - JOUR AU - Bibbins-Domingo, K. PY - 2016 DA - 2016// TI - Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: U.S. preventive services task force recommendation statementAspirin use for the Primary Prevention of CVD and CRC JO - Ann Intern Med VL - 164 UR - https://doi.org/10.7326/M16-0577 DO - 10.7326/M16-0577 ID - Bibbins-Domingo2016 ER - TY - JOUR AU - Hoftiezer, J. W. AU - Silvoso, G. R. AU - Burks, M. AU - Ivey, K. J. PY - 1980 DA - 1980// TI - Comparison of the effects of regular and enteric-coated aspirin on gastroduodenal mucosa of man JO - Lancet VL - 2 UR - https://doi.org/10.1016/S0140-6736(80)90282-2 DO - 10.1016/S0140-6736(80)90282-2 ID - Hoftiezer1980 ER - TY - JOUR AU - Mo, C. AU - Sun, G. AU - Lu, M. L. AU - Zhang, L. AU - Wang, Y. Z. AU - Sun, X. PY - 2015 DA - 2015// TI - Proton pump inhibitors in prevention of low-dose aspirin-associated upper gastrointestinal injuries JO - World J Gastroenterol VL - 21 UR - https://doi.org/10.3748/wjg.v21.i17.5382 DO - 10.3748/wjg.v21.i17.5382 ID - Mo2015 ER - TY - JOUR AU - Nagata, N. AU - Niikura, R. AU - Aoki, T. AU - Shimbo, T. AU - Kishida, Y. AU - Sekine, K. PY - 2014 DA - 2014// TI - Colonic diverticular hemorrhage associated with the use of nonsteroidal anti-inflammatory drugs, low-dose aspirin, antiplatelet drugs, and dual therapy JO - J Gastroenterol Hepatol VL - 29 UR - https://doi.org/10.1111/jgh.12595 DO - 10.1111/jgh.12595 ID - Nagata2014 ER - TY - JOUR AU - Stampfer, M. J. AU - Jakubowski, J. A. AU - Deykin, D. AU - Schafer, A. I. AU - Willett, W. C. AU - Hennekens, C. H. PY - 1986 DA - 1986// TI - Effect of alternate-day regular and enteric-coated aspirin on platelet aggregation, bleeding time, and thromboxane A2 levels in bleeding-time blood JO - Am J Med VL - 81 UR - https://doi.org/10.1016/0002-9343(86)90289-5 DO - 10.1016/0002-9343(86)90289-5 ID - Stampfer1986 ER - TY - JOUR AU - Targownik, L. PY - 2018 DA - 2018// TI - Discontinuing Long-Term PPI Therapy: why, with whom, and how? JO - Am J Gastroenterol VL - 113 UR - https://doi.org/10.1038/ajg.2018.29 DO - 10.1038/ajg.2018.29 ID - Targownik2018 ER - TY - JOUR AU - Hills, B. A. AU - Butler, B. D. AU - Lichtenberger, L. M. PY - 1983 DA - 1983// TI - Gastric-mucosal barrier - hydrophobic lining to the lumen of the stomach JO - Am J Physiol VL - 244 ID - Hills1983 ER - TY - JOUR AU - Lichtenberger, L. M. AU - Graziani, L. A. AU - Dial, E. J. AU - Butler, B. D. AU - Hills, B. A. PY - 1983 DA - 1983// TI - Role of surface-active phospholipids in gastric cytoprotection JO - Science VL - 219 UR - https://doi.org/10.1126/science.6828859 DO - 10.1126/science.6828859 ID - Lichtenberger1983 ER - TY - JOUR AU - Lichtenberger, L. M. AU - Wang, Z. M. AU - Romero, J. J. AU - Ulloa, C. AU - Perez, J. C. AU - Giraud, M. N. PY - 1995 DA - 1995// TI - Nonsteroidal Antiinflammatory drugs (Nsaids) associate with Zwitterionic phospholipids - insight into the mechanism and reversal of Nsaid-induced gastrointestinal injury JO - Nat Med VL - 1 UR - https://doi.org/10.1038/nm0295-154 DO - 10.1038/nm0295-154 ID - Lichtenberger1995 ER - TY - JOUR AU - Lichtenberger, L. M. AU - Phan, T. AU - Okabe, S. PY - 2011 DA - 2011// TI - Aspirin's ability to induce intestinal injury in rats is dependent on bile and can be reversed if pre-associated with phosphatidylcholine JO - J Physiol Pharmacol VL - 62 ID - Lichtenberger2011 ER - TY - JOUR AU - Angiolillo, D. J. AU - Bhatt, D. L. AU - Lanza, F. AU - Cryer, B. AU - Dong, J. F. AU - Jeske, W. PY - 2019 DA - 2019// TI - Pharmacokinetic/pharmacodynamic assessment of a novel, pharmaceutical lipid-aspirin complex: results of a randomized, crossover, bioequivalence study JO - J Thromb Thrombolysis VL - 48 UR - https://doi.org/10.1007/s11239-019-01933-7 DO - 10.1007/s11239-019-01933-7 ID - Angiolillo2019 ER - TY - JOUR AU - Cryer, B. AU - Bhatt, D. L. AU - Lanza, F. L. AU - Dong, J. F. AU - Lichtenberger, L. M. AU - Marathi, U. K. PY - 2011 DA - 2011// TI - Low-dose Aspirin-induced ulceration is attenuated by Aspirin-Phosphatidylcholine: a randomized clinical trial JO - Am J Gastroenterol VL - 106 UR - https://doi.org/10.1038/ajg.2010.436 DO - 10.1038/ajg.2010.436 ID - Cryer2011 ER - TY - JOUR AU - Lichtenberger, L. M. AU - Phan, T. AU - Fang, D. AU - Dial, E. J. PY - 2018 DA - 2018// TI - Chemoprevention with phosphatidylcholine non-steroidal anti-inflammatory drugs in vivo and in vitro JO - Oncol Lett VL - 15 ID - Lichtenberger2018 ER - TY - JOUR AU - Ritland, S. R. AU - Gendler, S. J. PY - 1999 DA - 1999// TI - Chemoprevention of intestinal adenomas in the ApcMin mouse by piroxicam: kinetics, strain effects and resistance to chemosuppression JO - Carcinogenesis VL - 20 UR - https://doi.org/10.1093/carcin/20.1.51 DO - 10.1093/carcin/20.1.51 ID - Ritland1999 ER - TY - JOUR AU - Wechter, W. J. AU - Kantoci, D. AU - Murray, E. D. AU - Quiggle, D. D. AU - Leipold, D. D. AU - Gibson, K. M. PY - 1997 DA - 1997// TI - R-flurbiprofen chemoprevention and treatment of intestinal adenomas in the APC (min)/+ mouse model: implications for prophylaxis and treatment of colon cancer JO - Cancer Res VL - 57 ID - Wechter1997 ER - TY - JOUR AU - Jacoby, R. F. AU - Seibert, K. AU - Cole, C. E. AU - Kelloff, G. AU - Lubet, R. A. PY - 2000 DA - 2000// TI - The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis JO - Cancer Res VL - 60 ID - Jacoby2000 ER - TY - JOUR AU - Murphy, E. A. AU - Davis, J. M. AU - McClellan, J. L. AU - Gordon, B. T. AU - Carmichael, M. D. PY - 2011 DA - 2011// TI - Curcumin’s effect on intestinal inflammation and tumorigenesis in the ApcMin/+ mouse JO - J Interf Cytokine Res VL - 31 UR - https://doi.org/10.1089/jir.2010.0051 DO - 10.1089/jir.2010.0051 ID - Murphy2011 ER - TY - JOUR AU - Paulsen, J. E. AU - Elvsaas, I. K. AU - Steffensen, I. L. AU - Alexander, J. PY - 1997 DA - 1997// TI - A fish oil derived concentrate enriched in eicosapentaenoic and docosahexaenoic acid as ethyl ester suppresses the formation and growth of intestinal polyps in the min mouse JO - Carcinogenesis VL - 18 UR - https://doi.org/10.1093/carcin/18.10.1905 DO - 10.1093/carcin/18.10.1905 ID - Paulsen1997 ER - TY - JOUR AU - Chiu, C. H. AU - McEntee, M. F. AU - Whelan, J. PY - 1997 DA - 1997// TI - Sulindac causes rapid regression of preexisting tumors in min/+ mice independent of prostaglandin biosynthesis JO - Cancer Res VL - 57 ID - Chiu1997 ER - TY - JOUR AU - Barnes, C. J. AU - Lee, M. PY - 1998 DA - 1998// TI - Chemoprevention of spontaneous intestinal adenomas in the adenomatous polyposis coli min mouse model with aspirin JO - Gastroenterology VL - 114 UR - https://doi.org/10.1016/S0016-5085(98)70305-1 DO - 10.1016/S0016-5085(98)70305-1 ID - Barnes1998 ER - TY - JOUR AU - Chiu, C. H. AU - McEntee, M. F. AU - Whelan, J. PY - 2000 DA - 2000// TI - Discordant effect of aspirin and indomethacin on intestinal tumor burden in Apc (min/+)mice JO - Prostaglandins Leukot Essent Fatty Acids VL - 62 UR - https://doi.org/10.1054/plef.2000.0154 DO - 10.1054/plef.2000.0154 ID - Chiu2000 ER - TY - JOUR AU - Mahmoud, N. N. AU - Dannenberg, A. J. AU - Mestre, J. AU - Bilinski, R. T. AU - Churchill, M. R. AU - Martucci, C. PY - 1998 DA - 1998// TI - Aspirin prevents tumors in a murine model of familial adenomatous polyposis JO - Surgery VL - 124 UR - https://doi.org/10.1016/S0039-6060(98)70124-2 DO - 10.1016/S0039-6060(98)70124-2 ID - Mahmoud1998 ER - TY - JOUR AU - Reuter, B. K. AU - Zhang, X. J. AU - Miller, M. J. S. PY - 2002 DA - 2002// TI - Therapeutic utility of aspirin in the ApcMin/+ murine model of colon carcinogenesis JO - BMC Cancer VL - 2 UR - https://doi.org/10.1186/1471-2407-2-19 DO - 10.1186/1471-2407-2-19 ID - Reuter2002 ER - TY - JOUR AU - Sansom, O. J. AU - Stark, L. A. AU - Dunlop, M. G. AU - Clarke, A. R. PY - 2001 DA - 2001// TI - Suppression of intestinal and mammary neoplasia by lifetime administration of aspirin in Apc (min/+) and Apc (min/+), Msh2(−/−) mice JO - Cancer Res VL - 61 ID - Sansom2001 ER - TY - JOUR AU - Wang, R. AU - Wang, Y. AU - Gao, Z. AU - Qu, X. PY - 2014 DA - 2014// TI - The comparative study of acetyl-11-keto-beta-boswellic acid (AKBA) and aspirin in the prevention of intestinal adenomatous polyposis in APC (min/+) mice JO - Drug Discov Ther VL - 8 UR - https://doi.org/10.5582/ddt.8.25 DO - 10.5582/ddt.8.25 ID - Wang2014 ER - TY - JOUR AU - Lynch, P. M. PY - 2016 DA - 2016// TI - Chemoprevention of familial adenomatous polyposis JO - Familial Cancer VL - 15 UR - https://doi.org/10.1007/s10689-016-9901-9 DO - 10.1007/s10689-016-9901-9 ID - Lynch2016 ER - TY - JOUR AU - Nair, A. B. AU - Jacob, S. PY - 2016 DA - 2016// TI - A simple practice guide for dose conversion between animals and human JO - J Basic Clin Pharm VL - 7 UR - https://doi.org/10.4103/0976-0105.177703 DO - 10.4103/0976-0105.177703 ID - Nair2016 ER - TY - JOUR AU - Huang, Y. AU - Lichtenberger, L. M. AU - Taylor, M. AU - Bottsford-Miller, J. N. AU - Haemmerle, M. AU - Wagner, M. J. PY - 2016 DA - 2016// TI - Antitumor and Antiangiogenic effects of Aspirin-PC in ovarian Cancer JO - Mol Cancer Ther VL - 15 UR - https://doi.org/10.1158/1535-7163.MCT-16-0074 DO - 10.1158/1535-7163.MCT-16-0074 ID - Huang2016 ER - TY - STD TI - Sulindac Compound Summary. https://pubchem.ncbi.nlm.nih.gov/compound/Sulindac. Accessed 8 Apr 2020. UR - https://pubchem.ncbi.nlm.nih.gov/compound/Sulindac ID - ref31 ER - TY - JOUR AU - Shiff, S. J. AU - Rigas, B. PY - 1999 DA - 1999// TI - The role of cyclooxygenase inhibition in the antineoplastic effects of nonsteroidal antiinflammatory drugs (NSAIDs) JO - J Exp Med VL - 190 UR - https://doi.org/10.1084/jem.190.4.445 DO - 10.1084/jem.190.4.445 ID - Shiff1999 ER - TY - JOUR AU - Pan, Y. AU - Jiang, Y. AU - Tan, L. AU - Ravoori, M. K. AU - Gagea, M. AU - Kundra, V. PY - 2015 DA - 2015// TI - Deletion of cyclooxygenase-2 inhibits K-ras-induced lung carcinogenesis JO - Oncotarget VL - 6 UR - https://doi.org/10.18632/oncotarget.5558 DO - 10.18632/oncotarget.5558 ID - Pan2015 ER - TY - JOUR AU - Giardiello, F. M. AU - Yang, V. W. AU - Hylind, L. M. AU - Krush, A. J. AU - Petersen, G. M. AU - Trimbath, J. D. PY - 2002 DA - 2002// TI - Primary chemoprevention of familial adenomatous polyposis with sulindac JO - N Engl J Med VL - 346 UR - https://doi.org/10.1056/NEJMoa012015 DO - 10.1056/NEJMoa012015 ID - Giardiello2002 ER - TY - JOUR AU - Koornstra, J. J. AU - Rijcken, F. E. AU - Oldenhuis, C. N. AU - Zwart, N. AU - Sluis, T. AU - Hollema, H. PY - 2005 DA - 2005// TI - Sulindac inhibits beta-catenin expression in normal-appearing colon of hereditary nonpolyposis colorectal cancer and familial adenomatous polyposis patients JO - Cancer Epidemiol Biomark Prev VL - 14 UR - https://doi.org/10.1158/1055-9965.EPI-05-0112 DO - 10.1158/1055-9965.EPI-05-0112 ID - Koornstra2005 ER - TY - JOUR AU - Boon, E. M. AU - Keller, J. J. AU - Wormhoudt, T. A. AU - Giardiello, F. M. AU - Offerhaus, G. J. AU - Neut, R. PY - 2004 DA - 2004// TI - Sulindac targets nuclear beta-catenin accumulation and Wnt signalling in adenomas of patients with familial adenomatous polyposis and in human colorectal cancer cell lines JO - Br J Cancer VL - 90 UR - https://doi.org/10.1038/sj.bjc.6601505 DO - 10.1038/sj.bjc.6601505 ID - Boon2004 ER - TY - JOUR AU - Brand, L. AU - Munding, J. AU - Pox, C. P. AU - Ziebarth, W. AU - Reiser, M. AU - Huppe, D. PY - 2013 DA - 2013// TI - Ss-catenin, cox-2 and p53 immunostaining in colorectal adenomas to predict recurrence after endoscopic polypectomy JO - Int J Color Dis VL - 28 UR - https://doi.org/10.1007/s00384-013-1667-z DO - 10.1007/s00384-013-1667-z ID - Brand2013 ER -